2-(1,3-benzodioxol-5-ylamino)-N-benzyl-4-(2-fluorophenyl)-N-propan-2-ylpyrimidine-5-carboxamide
C28H25FN4O3 — CID 59421170
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(1,3-benzodioxol-5-ylamino)-N-benzyl-4-(2-fluorophenyl)-N-propan-2-ylpyrimidine-5-carboxamide
2-(1,3-benzodioxol-5-ylamino)-N-benzyl-4-(2-fluorophenyl)-N-propan-2-ylpyrimidine-5-carboxamide (PubChem CID 59421170) has the molecular formula C28H25FN4O3 and a molecular weight of 484.53 g/mol. Its IUPAC name is 2-(1,3-benzodioxol-5-ylamino)-N-benzyl-4-(2-fluorophenyl)-N-propan-2-ylpyrimidine-5-carboxamide.
Molecular Properties
| Compound Name | 2-(1,3-benzodioxol-5-ylamino)-N-benzyl-4-(2-fluorophenyl)-N-propan-2-ylpyrimidine-5-carboxamide |
|---|---|
| PubChem CID | 59421170 |
| Molecular Formula | C28H25FN4O3 |
| Molecular Weight | 484.53 g/mol |
| Exact Mass | 484.19 |
| IUPAC Name | 2-(1,3-benzodioxol-5-ylamino)-N-benzyl-4-(2-fluorophenyl)-N-propan-2-ylpyrimidine-5-carboxamide |
| SMILES | CC(C)N(Cc1ccccc1)C(=O)c1cnc(Nc2ccc3c(c2)OCO3)nc1-c1ccccc1F |
| InChI | InChI=1S/C28H25FN4O3/c1-18(2)33(16-19-8-4-3-5-9-19)27(34)22-15-30-28(32-26(22)21-10-6-7-11-23(21)29)31-20-12-13-24-25(14-20)36-17-35-24/h3-15,18H,16-17H2,1-2H3,(H,30,31,32) |
| InChIKey | MPWDXSVPVHXOKQ-UHFFFAOYSA-N |
| XLogP | 5.81 |
| TPSA | 76.58 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 484.53 |
| LogP ≤ 5 | 5.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59421170 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.